Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you forgot to take your Mounjaro dose, the action you take depends on how much time has passed since your usual injection day. Take the missed dose as soon as you remember — but only if your next scheduled dose is still at least four days away. If fewer than four days remain, skip the missed dose entirely and carry on with your normal schedule. The NHS medicines page for tirzepatide sets this out clearly: never take two doses within four days of each other. As a prescription-only medicine, any bigger questions about your personal schedule are best put to your prescriber rather than a general guide like this one.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The first thing to do when you realise you forgot to take your Mounjaro dose is check the date. Count forward to your next scheduled injection day. If there are four or more days between now and that day, you can take the missed dose immediately. Your new weekly schedule then shifts to match whichever day you injected, so if you normally inject on a Monday but you take the missed dose on a Thursday, Thursday becomes your new day going forward.
If fewer than four days remain before your next dose is due, leave it. Take your next dose on the scheduled day as planned and carry on. It feels counterintuitive to skip it entirely, but that four-day gap exists to protect you from a surge of the medicine that your body has not had time to adjust to. Two doses in quick succession are more likely to cause nausea and other gastrointestinal discomfort than the medicine does at its usual pace.
One misconception worth letting go of: many people assume that missing a dose means their progress is lost, or that they need to go back to the start. That is not how tirzepatide works. A single missed injection does not undo weeks of treatment. Your appetite may return a little more strongly in the days around the gap, which is normal and temporary, and you can find reassurance and practical perspectives on experiences like this in our Mounjaro blogs.
When you take the dose (whether that is the missed one or your next scheduled one) the injection technique stays the same. Rotate your site: abdomen, thigh, or upper arm, avoiding the same spot as last time. The Mounjaro KwikPen delivers a fixed dose, so there is no adjustment needed. Store unused pens in the refrigerator at 2–8°C and check the Patient Information Leaflet for the maximum time a pen can remain at room temperature before use, since that window is specific to the product and worth confirming directly from the leaflet rather than from memory.
If you find you are regularly forgetting to take Mounjaro, it is worth linking the injection to a fixed weekly habit, a specific morning, a recurring diary reminder, the same day your bin goes out. Consistency matters less for the exact hour than for the day of the week. A useful overview of timing considerations can be found on our guide to when to take Mounjaro, which covers the best time of day and how to pick a day that works with your routine.
Some people also find it helpful to read through the full guidance on how to take Mounjaro periodically, especially when moving to a new dose strength, to make sure injection habits have not drifted.
A single forgotten dose is rarely a clinical issue. But there are situations where a conversation with your prescriber is sensible. If you have missed several doses in a row (particularly if it has happened because of side effects making you reluctant to inject) that is worth raising. Side effects at a given dose strength can sometimes be managed by slowing the titration, and your prescriber can advise on that. Pushing through significant discomfort without telling anyone is not the intended approach.
If you have missed doses because the medicine has been unavailable, that is a different situation again. Supply has been variable at points since Mounjaro launched. The cost and availability landscape has shifted since Eli Lilly adjusted UK list pricing in September 2025, and it is worth understanding what affects supply when you are planning ahead. Your prescriber or pharmacist can advise on whether a pause in treatment requires any change to your plan.
There is also a difference between forgetting a dose and deciding not to take it because of a new medication, a planned procedure, or a change in health. Those situations call for a clinical conversation before you make a decision rather than after. You can read about circumstances where pausing or skipping is genuinely advised on our page covering when not to take Mounjaro. For anything that does not fit a standard scenario, speaking to our prescribers is the clearest path to an answer that is specific to you.
Tirzepatide is the active ingredient in Mounjaro, a dual GIP and GLP-1 receptor agonist that is the only medicine of its kind currently licensed for weight management in the UK. If you want a fuller picture of how it works and what the clinical evidence behind it looks like, the tirzepatide overview covers the mechanism and the trial data in detail.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.